GL1X · GenesisL1 explorer

Research workbench

Crystal structure of MAP2K7 complexed with a covalent inhibitor 12

Analyse Crystal structure of MAP2K7 complexed with a covalent inhibitor 12 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7CBX
Type
protein
Length
281 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity mitogen-activated protein kinase kinase 7
EC
2.7.12.2
UniProt
O14733
Ligands
FU6
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity mitogen-activated protein kinase kinase 7 (EC 2.7.12.2)protein28141% helix, 18% strandO14733

Ligands and binding sites

  • FU6 · 3-(1H-indazol-3-yl)-5-(prop-2-enoylamino)-N-prop-2-ynyl-benzamide · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12290.690.8529FU6
2980.350.7423empty
3740.330.7517empty

Compared structures

  • 7CBX · Crystal structure of MAP2K7 complexed with a covalent inhibitor 12 · the same entry in another collection · chain A against A, TM-score 1.00
  • O14733 · AlphaFold monomer V2.0 prediction for dual specificity mitogen- activated protein kinase… · a predicted model of the same protein · chain A against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.